Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895345-25-000072·Akebia Therapeutics, Inc.
Schedule 13G ownership disclosure
Akebia Therapeutics Inc
Common Stock, par value $0.00001 · CUSIP: 00972D105
Event date: 2024-12-31
- Filing-level shares
- 5,747,906
- Percent of class
- 2.6%
- Satter Muneer A
Shares: 5,747,906 · Class: 2.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895345-25-000072
- Form type
- SCHEDULE 13G/A
- Filer
- Akebia Therapeutics, Inc.
- CIK
- CIK 1517022
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership